BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rothan HA, Stone S, Natekar J, Kumari P, Arora K, Kumar M. The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.. [DOI: 10.1101/2020.04.14.041228] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Musib D, Pal M, Allam US, Roy M. Brief History, Pathophysiology, Transmission of SARS-CoV-2 Virus, and Recent Advances on Transition Metal Complexes and Nanocomposites as the Potent Antiviral Agents from COVID-19 Perspectives. Materials Horizons: From Nature to Nanomaterials 2022. [DOI: 10.1007/978-981-16-8399-2_1] [Reference Citation Analysis]
2 Mallick R, Duttaroy AK. Clinical Features, Diagnostic Evaluation, and Management of COVID-19 Patients. Coronavirus Therapeutics – Volume II 2021. [DOI: 10.1007/978-3-030-85113-2_1] [Reference Citation Analysis]
3 Armstrong LA, Lange SM, de Cesare V, Matthews SP, Nirujogi RS, Cole I, Hope A, Cunningham F, Toth R, Mukherjee R, Bojkova D, Gruber F, Gray D, Wyatt PG, Cinatl J, Dikic I, Davies P, Kulathu Y. Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies.. [DOI: 10.1101/2020.12.09.417741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Marzo T, Messori L. A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin. ACS Med Chem Lett 2020;11:1067-8. [PMID: 32547693 DOI: 10.1021/acsmedchemlett.0c00190] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
5 Misra S, Nath M, Hadda V, Vibha D. Effect of various treatment modalities on the novel coronavirus (nCOV-2019) infection in humans: a systematic review & meta-analysis.. [DOI: 10.1101/2020.05.24.20111799] [Reference Citation Analysis]
6 [DOI: 10.1101/2020.04.20.049924] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Reference Citation Analysis]